Empowering knowledge

Welcome to the blog, your source for educational health information. We aim to empower you with evidenced-based insights into your body, genetics, and overall well-being. Join us as we explore topics designed to inform and inspire both individuals and corporations. Have questions? We encourage you to engage with our content and ask!

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome)

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) are immune-mediated neuropsychiatric disorders characterized by the abrupt onset of obsessive-compulsive behaviors, tics, and mood or anxiety disturbances. In PANDAS, the condition is triggered by Group A Streptococcus infections, whereas PANS can be precipitated by a broader range of infectious, inflammatory, or autoimmune events. Although historically described in children, emerging evidence suggests that adult-onset PANDAS/PANS may occur, likely due to lingering or reactivated autoimmune responses. Estimated prevalence in children is low, with PANDAS affecting roughly 0.2–1% of school-aged children, though exact rates are difficult to determine due to underdiagnosis and overlapping conditions. The underlying pathophysiology involves autoantibodies that cross-react with basal ganglia proteins (e.g., dopamine D1/D2 receptors, lysoganglioside GM1, and tubulin), triggering microglial activation, dopaminergic dysregulation, and disruption of cortico-striatal-thalamo-cortical circuits, which collectively produce the hallmark neuropsychiatric symptoms.

Read more »

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS)

ANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) are immune-mediated neuropsychiatric disorders characterized by the abrupt onset of obsessive-compulsive behaviors, tics, and mood or anxiety disturbances. In PANDAS, the condition is triggered by Group A Streptococcus infections, whereas PANS can be precipitated by a broader range of infectious, inflammatory, or autoimmune events. Although historically described in children, emerging evidence suggests that adult-onset PANDAS/PANS may occur, likely due to lingering or reactivated autoimmune responses. Estimated prevalence in children is low, with PANDAS affecting roughly 0.2–1% of school-aged children, though exact rates are difficult to determine due to underdiagnosis and overlapping conditions. The underlying pathophysiology involves autoantibodies that cross-react with basal ganglia proteins (e.g., dopamine D1/D2 receptors, lysoganglioside GM1, and tubulin), triggering microglial activation, dopaminergic dysregulation, and disruption of cortico-striatal-thalamo-cortical circuits, which collectively produce the hallmark neuropsychiatric symptoms.